These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 166902
1. The hypercholesterolaemia of obstructive jaundice. McIntyre N, Harry DS, Pearson AJ. Gut; 1975 May; 16(5):379-91. PubMed ID: 166902 [No Abstract] [Full Text] [Related]
2. Experiences with the homozygous cases of familial hypercholesterolemia. A report of 52 patients. Khachadurian AK, Uthman SM. Nutr Metab; 1973 May; 15(1):132-40. PubMed ID: 4351242 [No Abstract] [Full Text] [Related]
3. Xanthomatosis and hyperlipoproteinemia; a review. Polano MK. Dermatologica; 1974 May; 149(1):1-9. PubMed ID: 4372111 [No Abstract] [Full Text] [Related]
4. Bile acid metabolism in hyperlipoproteinaemia. Hellström K, Einarsson K. Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796 [No Abstract] [Full Text] [Related]
6. An effective treatment of hypercholesterolaemia using a combination of Secholex and clofibrate. Evans RJ, Howard AN, Hyams DE. Angiology; 1973 Jan; 24(1):22-8. PubMed ID: 4694031 [No Abstract] [Full Text] [Related]
7. [The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis]. Bavina MV, Perova NV, Lobova NM, Koropova GI. Kardiologiia; 1973 Mar; 13(3):27-33. PubMed ID: 4717180 [No Abstract] [Full Text] [Related]
8. Effect of combined clofibrate-cholestyramine treatment on serum and tissue cholesterol pools and on cholesterol synthesis in hypercholesterolemic swine. Kim DN, Lee KT, Reiner JM, Thomas WA. Exp Mol Pathol; 1975 Aug; 23(1):83-95. PubMed ID: 1157892 [No Abstract] [Full Text] [Related]
9. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia]. Carlson LA, Olsson AG, Orö L, Rössner S. Lakartidningen; 1974 Sep 04; 71(36):3289-91. PubMed ID: 4605566 [No Abstract] [Full Text] [Related]
10. Selective biliary obstruction: a model for the study of lipid metabolism in cholestasis. Cooper AD, Jones AL, Koldinger RE, Ockner RK. Gastroenterology; 1974 Apr 04; 66(4):574-85. PubMed ID: 4821080 [No Abstract] [Full Text] [Related]
13. Role of plasma and liver cholesterol- and lipoprotein-metabolism determinants in LpX formation in the mouse. Bravo I, Amigo L, Cohen DE, Nervi F, Rigotti A, Francone O, Zanlungo S. Biochim Biophys Acta; 2007 Jun 04; 1770(6):979-88. PubMed ID: 17399905 [Abstract] [Full Text] [Related]
14. Metabolism of plasma lipoproteins. Faergeman O. Acta Med Scand Suppl; 1977 Jun 04; 614():1-29. PubMed ID: 206106 [No Abstract] [Full Text] [Related]
15. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate. Roe DA. Arch Dermatol; 1968 Apr 04; 97(4):436-45. PubMed ID: 5643239 [No Abstract] [Full Text] [Related]
16. The primary hyperlipoproteinemias. Bybee DE, Hamilton RD. J Ky Med Assoc; 1974 Dec 04; 72(12):658-62. PubMed ID: 4373515 [No Abstract] [Full Text] [Related]
17. Combined use of clofibrate and cholestyramine or DEAE sephadex in hypercholesterolaemia. Howard AN, Hyams DE. Br Med J; 1971 Jul 03; 3(5765):25-7. PubMed ID: 4933388 [Abstract] [Full Text] [Related]